Elanco Animal Health ELAN
NYSE ELAN
$23.81 -0.16 (-0.69%)
As of: Sep 9, 2026 · 2:32 PM EDT

Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026)

Elanco Animal Health's (ELAN) quarterly Receivables - Other came in at $75.0 million in Q2 2026, down 34.21% year-over-year from $114.0 million in Q2 2025, and up 7.14% quarter-over-quarter from $70.0 million in Q1 2026.

Analysis

Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Receivables - Other across 10 years of filings, most recently posting $75.0 million for Q2 2026.

  • In Q2 2026, Receivables - Other fell 34.21% year-over-year to $75.0 million; the TTM figure through Jun 2026 stood at $75.0 million (down 34.21% YoY), while the FY2025 annual figure was $67.0 million, down 17.28% from the prior year.
  • Receivables - Other came in at $75.0 million for Q2 2026 at Elanco Animal Health, up from $70.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $225.0 million in Q2 2023 to a low of $64.0 million in Q3 2024.
  • Average Receivables - Other over 5 years is $139.1 million, with a median of $102.0 million recorded in 2024.
  • Year-over-year, Receivables - Other jumped 110.58% in 2022 and slumped 71.43% in 2024.
  • Over 5 years, Receivables - Other stood at $205.0 million in 2022, then dropped by 18.05% to $168.0 million in 2023, then sank by 51.79% to $81.0 million in 2024, then slipped by 17.28% to $67.0 million in 2025, then gained by 11.94% to $75.0 million in 2026.
  • Per Business Quant data, the three most recent Receivables - Other figures were $75.0 million in Q2 2026, $70.0 million in Q1 2026, and $67.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.52 Bn 40.33 Bn 779.09 Mn
2 Zoetis 30.69 Bn 29.02 Bn 1.05 Bn
3 Elanco Animal Health 11.89 Bn 11.36 Bn 798.00 Mn
4 Phibro Animal Health 1.50 Bn 1.42 Bn 134.40 Mn
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 75.05 Mn 67.96 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.00 Mn
Mar 31, 2026 70.00 Mn
Dec 31, 2025 67.00 Mn
Sep 30, 2025 81.00 Mn
Jun 30, 2025 114.00 Mn
Mar 31, 2025 90.00 Mn
Dec 31, 2024 81.00 Mn
Sep 30, 2024 64.00 Mn
Jun 30, 2024 81.00 Mn
Mar 31, 2024 90.00 Mn
Dec 31, 2023 168.00 Mn
Sep 30, 2023 224.00 Mn
Jun 30, 2023 225.00 Mn
Mar 31, 2023 213.00 Mn
Dec 31, 2022 205.00 Mn
Sep 30, 2022 224.00 Mn
Jun 30, 2022 212.00 Mn
Mar 31, 2022 219.00 Mn
Dec 31, 2021 195.00 Mn
Sep 30, 2021 158.00 Mn